Nuzenio

Oncology Reports

Oncology Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 11:30:00 GMTSix New Employees Receive Kura Oncology Options at $9.19 - Stock TitanStock Titan · Fri, 07 Aug 2026 11:30:00 GMTVerastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - BioSpaceBioSpace · Fri, 07 Aug 2026 10:26:31 GMTStarling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:35:56 GMTALX Oncology Reports Q2 2026 Net Loss of $18 Million - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 12:16:00 GMTCG Oncology expects bladder cancer trial data soon; cash through 2029 - Stock TitanStock Titan · Thu, 06 Aug 2026 12:15:00 GMTALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:00:00 GMTCoherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 20:28:00 GMT

Timeline

Fri, 07 Aug 2026 11:30:00 GMTKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance Singapore
Fri, 07 Aug 2026 11:30:00 GMTSix New Employees Receive Kura Oncology Options at $9.19 - Stock Titan
Fri, 07 Aug 2026 10:26:31 GMTVerastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - BioSpace
Thu, 06 Aug 2026 20:35:56 GMTStarling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance - The Manila Times
Thu, 06 Aug 2026 12:16:00 GMTALX Oncology Reports Q2 2026 Net Loss of $18 Million - Quiver Quantitative
Thu, 06 Aug 2026 12:15:00 GMTCG Oncology expects bladder cancer trial data soon; cash through 2029 - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oncology Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.